• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估阳性淋巴结对数优势比对喉癌患者术后生存的预测价值:一项基于监测、流行病学和最终结果(SEER)数据库人群的研究

Evaluating the predictive value of log odds of positive lymph nodes on postoperative survival in patients with laryngeal cancer: a SEER population-based study.

作者信息

Zhang Jiahui, Su Wenjun, Wang Yue, Zeng Peiji, Wang Wei, Fu Wenjie, Cai Chengfu

机构信息

Xiamen Hospital of Traditional Chinese Medicine, Xiamen, China.

Department of Otolaryngology-Head and Neck Surgery, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.

出版信息

Discov Oncol. 2025 Apr 2;16(1):452. doi: 10.1007/s12672-025-02193-z.

DOI:10.1007/s12672-025-02193-z
PMID:40175798
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11965040/
Abstract

Traditionally, the AJCC TNM staging system has been the primary tool for assessing the severity and prognosis of laryngeal cancer. Although several studies have demonstrated that the log odds of positive lymph nodes (LODDS) offers superior predictive accuracy compared to the TNM staging for other cancers, there is limited research for laryngeal cancer. This study analyzed data from SEER database (2000-2019). Independent risk factors for survival were identified using univariate and multivariate Cox regression analyses, and different prognostic models were constructed based on the multivariate analysis results. The predictive performance of these models was evaluated using receiver operating characteristic (ROC) curves and area under the curve (AUC) values. The results indicated that LODDS subgroup, age, marital status, histologic grade, T-stage, and N-stage were consistent independent prognostic factors for overall survival (OS) and cancer-specific survival (CSS). Assessment metrics showed that the multivariate model, which incorporated both LODDS and N staging, outperformed the individual N staging and LODDS models in predicting postoperative prognosis in laryngeal cancer patients. Overall, the multivariate model constructed in this study is a superior tool for predicting the postoperative status of laryngeal cancer.

摘要

传统上,美国癌症联合委员会(AJCC)的TNM分期系统一直是评估喉癌严重程度和预后的主要工具。尽管多项研究表明,与TNM分期相比,阳性淋巴结对数优势比(LODDS)对其他癌症具有更高的预测准确性,但针对喉癌的相关研究却很有限。本研究分析了监测、流行病学和最终结果(SEER)数据库(2000 - 2019年)中的数据。使用单因素和多因素Cox回归分析确定生存的独立危险因素,并根据多因素分析结果构建不同的预后模型。使用受试者工作特征(ROC)曲线和曲线下面积(AUC)值评估这些模型的预测性能。结果表明,LODDS亚组、年龄、婚姻状况、组织学分级、T分期和N分期是总生存期(OS)和癌症特异性生存期(CSS)一致的独立预后因素。评估指标显示,结合了LODDS和N分期的多因素模型在预测喉癌患者术后预后方面优于单独的N分期和LODDS模型。总体而言,本研究构建的多因素模型是预测喉癌术后状况的更优工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5ae/11965040/944b3e5fec24/12672_2025_2193_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5ae/11965040/dfd6487b6d9f/12672_2025_2193_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5ae/11965040/6a75bd8f9760/12672_2025_2193_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5ae/11965040/9f10cdd956a9/12672_2025_2193_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5ae/11965040/944b3e5fec24/12672_2025_2193_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5ae/11965040/dfd6487b6d9f/12672_2025_2193_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5ae/11965040/6a75bd8f9760/12672_2025_2193_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5ae/11965040/9f10cdd956a9/12672_2025_2193_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5ae/11965040/944b3e5fec24/12672_2025_2193_Fig4_HTML.jpg

相似文献

1
Evaluating the predictive value of log odds of positive lymph nodes on postoperative survival in patients with laryngeal cancer: a SEER population-based study.评估阳性淋巴结对数优势比对喉癌患者术后生存的预测价值:一项基于监测、流行病学和最终结果(SEER)数据库人群的研究
Discov Oncol. 2025 Apr 2;16(1):452. doi: 10.1007/s12672-025-02193-z.
2
A Nomogram Based on the Log Odds of Positive Lymph Nodes Predicts the Prognosis of Patients With Distal Cholangiocarcinoma After Surgery.基于阳性淋巴结对数比值的列线图预测远端胆管癌患者术后预后
Front Surg. 2021 Oct 26;8:757552. doi: 10.3389/fsurg.2021.757552. eCollection 2021.
3
Evaluation of log odds of positive lymph nodes in predicting the survival of patients with non-small cell lung cancer treated with neoadjuvant therapy and surgery: a SEER cohort-based study.基于 SEER 队列研究评估新辅助治疗联合手术治疗的非小细胞肺癌患者中阳性淋巴结对数优势比对生存的预测价值。
BMC Cancer. 2022 Jul 20;22(1):801. doi: 10.1186/s12885-022-09908-3.
4
A Prognostic Model Based on the Log Odds Ratio of Positive Lymph Nodes Predicts Prognosis of Patients with Rectal Cancer.基于阳性淋巴结对数优势比的预后模型预测直肠癌患者的预后。
J Gastrointest Cancer. 2024 Sep;55(3):1111-1124. doi: 10.1007/s12029-024-01046-2. Epub 2024 May 3.
5
Prognostic value of log odds of positive lymph nodes in node-positive lung squamous cell carcinoma patients after surgery: a SEER population-based study.手术治疗后淋巴结阳性的肺鳞状细胞癌患者中阳性淋巴结对数比的预后价值:一项基于监测、流行病学和最终结果(SEER)数据库人群的研究
Transl Lung Cancer Res. 2020 Aug;9(4):1285-1301. doi: 10.21037/tlcr-20-193.
6
Comparison of 4 lymph node staging systems for the prognostic prediction of esophagogastric junction adenocarcinoma with ≤15 retrieved lymph nodes.针对≤15枚检出淋巴结的食管胃交界腺癌预后预测的4种淋巴结分期系统比较
Eur J Surg Oncol. 2022 May;48(5):1017-1024. doi: 10.1016/j.ejso.2021.11.133. Epub 2021 Dec 1.
7
Construction and Validation of a Nomogram Based on the Log Odds of Positive Lymph Nodes to Predict the Prognosis of Medullary Thyroid Carcinoma After Surgery.基于阳性淋巴结对数优势构建并验证列线图预测甲状腺髓样癌术后预后
Ann Surg Oncol. 2021 Aug;28(8):4360-4370. doi: 10.1245/s10434-020-09567-3. Epub 2021 Jan 19.
8
Advantage of log odds of positive lymph nodes in prognostic evaluation of patients with early-onset colon cancer.阳性淋巴结对数优势比在早发性结肠癌患者预后评估中的作用
World J Gastrointest Surg. 2023 Nov 27;15(11):2430-2444. doi: 10.4240/wjgs.v15.i11.2430.
9
Construction and validation of a novel nomogram based on the log odds of positive lymph nodes to predict cancer-specific survival in elderly patients with gastric adenocarcinoma after radical surgery.基于阳性淋巴结对数比值构建并验证新型列线图以预测老年胃腺癌患者根治性手术后的癌症特异性生存情况。
BMC Gastroenterol. 2025 Apr 2;25(1):215. doi: 10.1186/s12876-025-03813-2.
10
Developing and validating a prognostic nomogram for ovarian clear cell carcinoma patients: A retrospective comparison of lymph node staging schemes with competing risk analysis.开发并验证卵巢透明细胞癌患者的预后列线图:基于竞争风险分析的淋巴结分期方案回顾性比较
Front Oncol. 2022 Nov 9;12:940601. doi: 10.3389/fonc.2022.940601. eCollection 2022.

本文引用的文献

1
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
2
Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: A Single-Arm Phase II Clinical Trial.诱导替雷利珠单抗联合化疗治疗局部晚期喉和声门下癌的保器官疗效:一项单臂 II 期临床试验。
Clin Cancer Res. 2024 Jan 17;30(2):344-355. doi: 10.1158/1078-0432.CCR-23-2398.
3
PD-1 Inhibitors combined with paclitaxel (Albumin-bound) and cisplatin for larynx preservation in locally advanced laryngeal and hypopharyngeal squamous cell carcinoma: a retrospective study.
PD-1 抑制剂联合紫杉醇(白蛋白结合型)和顺铂用于局部晚期喉和声门下鳞状细胞癌的喉保留:一项回顾性研究。
Cancer Immunol Immunother. 2023 Dec;72(12):4161-4168. doi: 10.1007/s00262-023-03550-z. Epub 2023 Oct 7.
4
Updates on Larynx Cancer: Risk Factors and Oncogenesis.喉癌研究进展:危险因素与发生机制
Int J Mol Sci. 2023 Aug 18;24(16):12913. doi: 10.3390/ijms241612913.
5
Efficacy and safety of pembrolizumab with preoperative neoadjuvant chemotherapy in patients with resectable locally advanced head and neck squamous cell carcinomas.帕博利珠单抗联合术前新辅助化疗治疗可切除局部晚期头颈部鳞状细胞癌患者的疗效和安全性。
Front Immunol. 2023 Jul 31;14:1189752. doi: 10.3389/fimmu.2023.1189752. eCollection 2023.
6
Swallowing Function After Treatment of Laryngeal Cancer.喉癌治疗后的吞咽功能。
Otolaryngol Clin North Am. 2023 Apr;56(2):371-388. doi: 10.1016/j.otc.2022.11.004.
7
Evaluating prognostic value and stage migration effects using a positive lymph node ratio in adenocarcinoma of the esophagogastric junction.评估食管胃结合部腺癌中阳性淋巴结比率的预后价值和分期迁移效应。
BMC Cancer. 2023 Mar 8;23(1):218. doi: 10.1186/s12885-023-10689-6.
8
Log Odds of Positive Lymph Nodes (LODDS) as an Independent Predictor of Overall Survival Following Radical Cystectomy in Urothelial Bladder Cancer: Time to Rethink Conventional Node Staging.淋巴结阳性对数比(LODDS)作为膀胱癌根治性膀胱切除术后总生存的独立预测因素:重新考虑传统淋巴结分期的时候到了。
Clin Genitourin Cancer. 2023 Jun;21(3):e175-e181. doi: 10.1016/j.clgc.2022.12.001. Epub 2022 Dec 7.
9
Evaluation of log odds of positive lymph nodes in predicting the survival of patients with non-small cell lung cancer treated with neoadjuvant therapy and surgery: a SEER cohort-based study.基于 SEER 队列研究评估新辅助治疗联合手术治疗的非小细胞肺癌患者中阳性淋巴结对数优势比对生存的预测价值。
BMC Cancer. 2022 Jul 20;22(1):801. doi: 10.1186/s12885-022-09908-3.
10
Number of Positive Lymph Nodes Combined with the Logarithmic Ratio of Positive Lymph Nodes predicts Survival in Patients with Non-Metastatic Larynx Squamous Cell Carcinoma.阳性淋巴结数量联合阳性淋巴结对数比值可预测非转移性喉鳞状细胞癌患者的生存情况。
J Cancer. 2022 Mar 14;13(6):1773-1784. doi: 10.7150/jca.67348. eCollection 2022.